199
panel
The Outsized Role of Philanthropy in Curing Rare and Emerging Diseases
With nearly 7,000 rare diseases affecting 30 million Americans, rare diseases are, in fact, not
so rare. According to the Orphan Drug Act of 1983, rare disease is defined as any disease affecting fewer than 200,000 Americans.
+ Read More
panel
Race Against Resistance: Overcoming Antibiotic Market Failures (Invite only)
Despite repeated warnings about the worldwide growth of antimicrobial resistance, the antibiotic
pipeline has failed to adequately grow to deliver new options for patients.
+ Read More
panel
FasterCures Advisory Groups Meeting (Invite only)
This session will bring together the FasterCures Advisory Board, Business Council, Nonprofit Cou
ncil, and Senior Fellows. Programmatic updates will be discussed and upcoming key events will be flagged for the engagement of all groups.
+ Read More
panel
The Center for the Future of Aging's Business Council Meeting (Invite only)
The world's population aged 60 and older will increase from 900 million to 2.1 billion by midcen
tury.
+ Read More
panel
Food Leaders' Retreat (Invite only)
The Food Leaders' Retreat series brings together a select group of corporate leaders, policymake
rs, entrepreneurs, investors, academics, and philanthropists to catalyze our effort to build a healthier, more sustainable food system.
+ Read More
panel
Networking and Refreshment Break
panel
Turning Back Time: The Science of Aging
As the population ages across the globe, governments, researchers, and businesses often focus on
the increased incidence of chronic diseases and strategies to manage these age-related chronic conditions.
+ Read More
panel
Redefining Philanthropic Drug Discovery
It's challenging to translate academic discoveries from the lab to the bedside. There are a numb
er of contributing factors—including limited resources, lack of expertise, and the high likelihood of failure—and the consequences are significant.
+ Read More
panel
Networking and Refreshment Break
panel
Reducing the Cost and Risk of Dementia
The Milken Institute projects that over the next 20 years, the prevalence of dementia in the US
will double from nearly 7.2 million to nearly 13 million, with women comprising about two-thirds of those expected to develop dementia.
+ Read More
panel
Age-Forward 2030: The Intersection of Housing and Health Care
Affordable housing and connected health services are the two most critical policy interventions
that local leaders need to prioritize before 2030 as they prepare for aging populations, according to a forthcoming Milken Institute survey.
+ Read More